logo

Stable Isotope Labeled Compounds Market Size (2024 - 2029)

The stable isotope labeled compounds market is anticipated to experience significant growth, driven by increased research and development activities, particularly in the biotechnology and pharmaceutical sectors. The market's expansion is further supported by the rising incidence of cancer, which underscores the importance of stable isotopes in cancer research and treatment. Additionally, advancements in the proteomics industry, facilitated by stable isotope labeling, are contributing to the market's growth trajectory. Despite these positive trends, the high cost of isotope compounds poses a challenge to market expansion.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Stable Isotope Labeled Compounds Industry Market Size

Market Size of Stable Isotope Labeled Compounds Industry

Stable Isotope Labeled Compounds Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 3.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Stable Isotope Labeled Compounds Market Major Players

*Disclaimer: Major Players sorted in no particular order

Stable Isotope Labeled Compounds Market Analysis

The stable isotope labeled compounds market is projected to witness a CAGR of nearly 3.3% over the forecast period.

The emergence of COVID-19 opened the doors for drastic R&D across the world. Companies were working hard to cope with the coronavirus and understand the effective way to manage the disease. The pandemic had a significant impact on the stable isotope-labeled compounds market as R&D was on the rise. For instance, in June 2020, Cambridge Isotobes Laboratory Inc. announced that the company was assisting the researchers at the Massachusetts Institute of Technology, Cambridge, to investigate the structure and dynamics of membrane proteins found in pathogenic viruses such as SARS-CoV 2 by supplying 3C6 glucose isotope which is used in E. coli-based protein expression to enrich SARS CoV 2 and also with 13C for the general requirement for NMR investigations of this type. As the use of stable isotopes labeled compounds increased for research during the pandemic, it is observed that the market was positively impacted. However, currently, the market is in its pre-pandemic phase and is expected to witness healthy growth in the coming years.

The major factor attributing to the growth of the market include the increase in the incidence of cancer and the growing investments in R&D programs by the biotechnology and pharmaceutical companies are boosting the market growth.

As per the data from the American Cancer Society report published in 2022, it is observed that there will be around 1.91 million new cancer cases in the United States during 2022. Among the cancer cases, cancers of the genital and digestive systems are expected to be the highest, with 395,600 and 343,040 new cases, respectively. The data published by PubMed in August 2021 stated that stable isotope tracing is an essential technology to study the molecular mechanisms by which nutraceuticals modulate and target cancer metabolism. Furthermore, the use of positionally labeled tracers as exogenous nutrients and the monitoring of their downstream metabolites labeling patterns enable the analysis of the specific metabolic pathway activity in cancer. Therefore, with the significance of stable isotopes in cancers, a high incidence of the disease is expected to propel market growth in the coming years.

Furthermore, there is growing research in the proteomics industry, which is augmenting the market growth. For instance, as per the data from the Journal of Proteomics and Bioinformatics data published in September 2022, rapid advancements in proteomics are enabling its high utilization in the treatment of infectious diseases across the world. Protein steady-state levels, protein turnover, and protein localization can all be determined using stable isotope labeling with mass spectrometry (MS)-based proteomic analysis. Hence, with the increasing research in proteomics research and the application of stable isotopes in the same, the market studied is expected to witness strong growth in the forecast period.

However, the high cost of the isotope compounds is the major drawback of the market.

Stable Isotope Labeled Compounds Industry Segmentation

As per the scope of the report, a stable isotope-labeled compound is a chemical substance in which part of the molecules are labeled with an isotope so that observations of the isotopic composition make it possible to follow the compound or its fragments through physical, chemical, or biological processes. 

The Stable Isotope Labeled Compounds Market is Segmented by Type (Deuterium, Carbon-13, Oxygen-18, and Other Stable Isotopes), Application (Research and Development, Clinical Diagnostics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value in USD million for the above segments. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above segments.

By Type
Deuterium
Carbon-13
Oxygen-18
Other Stable Isotopes
By Application
Research and Development
Clinical Diagnostics
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Stable Isotope Labeled Compounds Market Size Summary

The stable isotope labeled compounds market is poised for steady growth, driven by increased research and development activities, particularly in the fields of biotechnology and pharmaceuticals. The market experienced a positive impact during the COVID-19 pandemic as the demand for stable isotopes surged to support research on pathogenic viruses. This trend has continued as the market transitions back to its pre-pandemic phase, with a focus on addressing the rising incidence of cancer and the growing need for advanced research methodologies. The application of stable isotopes in cancer research, particularly in understanding cancer metabolism through stable isotope tracing, is expected to be a significant growth driver. Additionally, advancements in proteomics, facilitated by stable isotope labeling, are further propelling market expansion, as these technologies are increasingly utilized in the treatment of infectious diseases.

North America is anticipated to lead the market, supported by a robust healthcare infrastructure, a high prevalence of cancer, and significant investments in research and development. The United States, in particular, is witnessing substantial funding for stable isotope research, which is expected to bolster market growth. The presence of key industry players and strategic partnerships, such as those between Fusion Pharmaceuticals Inc. and TRIUMF, are also contributing to the market's expansion. Despite the high cost of isotope compounds posing a challenge, the market remains moderately competitive with major companies like PerkinElmer Inc. and Merck KGaA playing pivotal roles. Overall, the stable isotope labeled compounds market is set to experience significant growth, driven by technological advancements and increasing applications across various scientific fields.

Explore More

Stable Isotope Labeled Compounds Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Proteomics Research

      2. 1.2.2 Rising Prevalence of Cancer

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Skilled Labour

      2. 1.3.2 High Cost of Stable Isotope-Labeled Compounds

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Type

      1. 2.1.1 Deuterium

      2. 2.1.2 Carbon-13

      3. 2.1.3 Oxygen-18

      4. 2.1.4 Other Stable Isotopes

    2. 2.2 By Application

      1. 2.2.1 Research and Development

      2. 2.2.2 Clinical Diagnostics

      3. 2.2.3 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Stable Isotope Labeled Compounds Market Size FAQs

The Stable Isotope Labeled Compounds Market is projected to register a CAGR of 3.30% during the forecast period (2024-2029)

PerkinElmer Inc, Merck KGaA, Cambridge Isotope Laboratories, Inc., JSC Isotope. and Medical Isotopes, Inc. are the major companies operating in the Stable Isotope Labeled Compounds Market.

Isotope Labelled Compounds Market Report Snapshots

Stable Isotope Labeled Compounds Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)